Explore more Categories
Artificial Intelligence involves the science and engineering of developing intelligent machines
The manufacturing world is at a cusp of a new revolution that will redefine conventional business models
IoT will have a major impact on businesses and consumers in the future
The world is creating 2.5 exabytes of data daily
Our research seeks to connect-the-dots across multiple trends
Personal Robots are Set to Be a $19 Billion Market
Strategic Analysis of BREXIT and its Implications to Industries, Economies and Societies
iFrost is a digital platform for interactive and dynamic reporting of data.
The TOEs are a great source of information which gives corporates critical information on companies to action for their strategic investments either as an open source platform or to collaborate and to develop successful products
Translating Technology Innovation to Market Competitiveness
* Required Fields
Pay by invoice
Overall Impact of Biomanufacturing Technology InnovationsImpact on Unmet NeedsPharmaceutical companies perceive analytical services as important. There is a need for a robust platform that enables the provision of such services. Pharma firms are outsourcing crucial processes and are utilizing services such as analytics, research, process development, bio-analytical testing, and regulatory support. Impact on Capturing Investment OpportunitiesAs the biologics market is witnessing increased outsourcing of mammalian cell culture activities, a significant expansion of capacity is expected in this area. Biopharma companies will outsource cell line development to specialist vendors, including professional biological contract manufacturing organizations (BioCMOs), or license it from them.Impact on Technology ImplementationContract development and manufacturing organizations (CDMOs) need to focus on the attractive opportunity in disposables/ single use bioreactors, improvements in upstream & downstream technologies, advances in lyophilisation & increased application of PAT, continuous bio-manufacturing, new cell culture techniques, and modular facilities/pod manufacturing. Impact on Strategic CollaborationsCDMOs need to broaden their services to grab emerging opportunities in outsourcing of biologic and biosimilar manufacturing driven by mid and small biotech names. Large BioCDMOs will continue to invest in drug development and clinical manufacturing capabilities through M&A activities.Impact on Disruptive Business ModelsExpanding services of CMOs into the early-stage development of drugs, emergence of virtual biotech, out-licensing, and risk sharing between pharma and CMOs is disrupting the traditional business models. By offering value-added services to pharma companies, CMOs need to redefine themselves as CDMOs and integrate themselves into the value chain of companies.
Global Single Cell Proteomics and Genomics Market
Analysis of the Drug Delivery Devices Market
Market Assessment of Global Refurbished Medical Imaging Equipments
Future of Neurodegenerative Disorder Therapeutics; Forecast to 2024
Innovations in Microbiome, Small Molecules, Biologics, and Biotech Platforms
Growth Opportunities in the Global Radiology-as-a-Service Market, Forecast to 2023
Innovations in Medical Device Implants, Neurostimulation, Surgical Interventions, and Smart Diagnostics
Image-guided Navigation Technologies Providing Surgical Guidance
Disruptive Technologies in Digital Health
HealthWear Enabling Continuous Monitoring and Remote Therapies
diet food market
functional beverage market
virtual reality market
renewable energy market
power electronics market
fleet management market
Fill in the fields below to receive a sample report
Don't have an account? Create One!
Enter your Email Address here to receive a link to change password.
If you are an existing frost.com user, please register using the same email for seamless access
Already have an account? Login!
Use your Linkedin account to login or register within our store.You're just one click away.